MedPath

Onkovis GmbH

๐Ÿ‡ฉ๐Ÿ‡ชGermany
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:0
Completed:4

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

A Non Interventional Study With Oxaliplatin Onkovis (Oxaliplatin) Utilized for the Treatment of Cancer

Completed
Conditions
Carcinoma
First Posted Date
2013-09-13
Last Posted Date
2018-08-07
Lead Sponsor
Onkovis GmbH
Target Recruit Count
383
Registration Number
NCT01942200
Locations
๐Ÿ‡ฉ๐Ÿ‡ช

Practice, Naunhof, Germany

A Non Interventional Study With Irinotecan Onkovis (Irinotecan) Utilized for the Treatment of Cancer

Completed
Conditions
Carcinoma
First Posted Date
2013-04-25
Last Posted Date
2018-05-23
Lead Sponsor
Onkovis GmbH
Target Recruit Count
324
Registration Number
NCT01840280
Locations
๐Ÿ‡ฉ๐Ÿ‡ช

Practice, Werdau, Germany

A Non Interventional Study With Paclitaxel Onkovis (Paclitaxel) Utilized for the Treatment of Cancer

Completed
Conditions
Carcinoma
First Posted Date
2012-08-17
Last Posted Date
2018-07-16
Lead Sponsor
Onkovis GmbH
Target Recruit Count
770
Registration Number
NCT01668108
Locations
๐Ÿ‡ฉ๐Ÿ‡ช

Practice, Plauen, Germany

A Non Interventional Study With Doce Onkovis (Docetaxel) Utilized for the Treatment of Cancer

Completed
Conditions
Carcinoma
First Posted Date
2012-06-07
Last Posted Date
2015-06-04
Lead Sponsor
Onkovis GmbH
Target Recruit Count
371
Registration Number
NCT01614002
Locations
๐Ÿ‡ฉ๐Ÿ‡ช

Practice, Zwickau, Germany

๐Ÿ‡ฉ๐Ÿ‡ช

Hospital, Leipzig, Germany

๐Ÿ‡ฉ๐Ÿ‡ช

Clinic, Torgau, Germany

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

ยฉ 2025 MedPath, Inc. All rights reserved.